Silver Spring, MD - The US Food and Drug Administration (FDA) has granted approval of the first generic formulation of enoxaparin (Lovenox, Sanofi-Aventis) sodium injection, a low-molecular-weight ...
Patients exposed to a higher dose may be subject to bleeding complications. Apotex Corp announced the voluntary recall of 2 batches of Enoxaparin Sodium Injection ...
(RTTNews) - Sandoz, Inc., an unit of Novartis Pharma AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high ...
Princeton, New Jersey, April 25, 2012 – Sandoz today announced the introduction of enoxaparin sodium injection, USP 3 mL vials, a generic version of Sanofi's Lovenox® Injection Multiple-Dose Vials, in ...
It is indicated alone or in combination with warfarin to prevent and treat blood clots in the leg. It is a low molecular weight heparin. Enoxaparin is indicated for preventing and treating blood clots ...
The Department of Pharmaceuticals (DoP) has rejected a review application of Sanofi India, part of the leading multinational pharma major Sanofi, and upheld the decision of National Pharmaceutical ...
July 26, 2010 — The US Food and Drug Administration (FDA) has approved the first generic formulation of enoxaparin sodium injection (Sandoz, Inc; brand name, Lovenox; Sanofi-Aventis US, LLC), a ...
The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback